Sequencing HER2+ MBC

CE / CME

Sequencing HER2-Positive MBC: Expert Insights and Emerging Data

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Pharmacists: 0.50 contact hour (0.05 CEUs)

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: March 24, 2025

Expiration: September 23, 2025

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

When discussing treatment plans with colleagues and patients, how confident are you in summarizing the recommended sequencing of HER2-targeted therapies for HER2+ MBC treatment based on the latest data and clinical guidelines?

2.

Which of the following were key findings of the HER2CLIMB-02 trial evaluating tucatinib + T-DM1 vs T-DM1 + placebo for the treatment of previously treated HER2+ MBC?